 |
 |
|
|
RESÚMENES JULIO 2007 |
Addictive Disorders
(Haga un click en la información del journal para acceder al resúmen)
Heroin-assisted
treatment for opioid dependence.
Randomised controlled trial
Christian Haasen, Uwe Verthein, Peter
Degkwitz, Juergen Berger, Michael Krausz, Dieter Naber
The British Journal of Psychiatry (2007) 191: 55-62
Brain
opioid receptor binding in early abstinence from opioid dependence. Positron emission
tomography study
Tim M. Williams, Mark R. C. Daglish, Anne Lingford-Hughes, Lindsay G. Taylor, Alexander Hammers,
David J. Brooks, Paul Grasby, Judith S. Myles, David
J. Nutt
The British Journal of Psychiatry (2007) 191: 63-69
Pharmacological
treatment of addiction
Ben
Watson and Anne Lingford-Hughes
Psychiatry. Volume 6, Issue 7, July
2007, Pages 309-312
TEXTO GRATUITO
Is Cocaine Desire
Reduced by N-Acetylcysteine?
Steven D. LaRowe, Hugh Myrick, Sarra Hedden, Pascale
Mardikian, Michael Saladin, Aimee McRae, Kathleen
Brady, Peter W. Kalivas, and Robert Malcolm
Am J Psychiatry
164:1115-1117, July 2007
Prevalence, Correlates, Disability, and Comorbidity of DSM-IV
Alcohol Abuse and Dependence in the
Deborah S. Hasin, Frederick S. Stinson, Elizabeth
Ogburn, Bridget F. Grant
Arch Gen Psychiatry. 2007;64:830-842
Axis I and II disorders as long-term predictors of mental
distress: A six-year prospective follow-up of substance-dependent patients
BMC Psychiatry 2007, 7:29
TEXTO
GRATUITO
Rationale,
pharmacology and clinical efficacy of partial agonists of α4β2
nACh receptors for smoking cessation
Hans Rollema, Jotham W. Coe, Leslie K.
Chambers, Raymond S. Hurst, Stephen M. Stahl and Kathryn E. Williams
Trends in Pharmacological
Sciences.
Volume 28, Issue 7, July 2007, Pages 316-325
Managing smoking
cessation
Paul Aveyard, Robert West
TEXTO
GRATUITO
Memantine produces modest reductions in heroin-induced subjective responses in
human research volunteers
Sandra D. Comer
and Maria A. Sullivan
Psychopharmacology. Volume 193, Number 2 / August, 2007: 235-245
Ecstasy induces
apoptosis via 5-HT2A-receptor stimulation in cortical neurons
João Paulo Capela, Eduarda Fernandes, Fernando Remião, Maria
Lourdes Bastos, Andreas Meisel
and Félix Carvalho
NeuroToxicology. Volume 28, Issue 4, July 2007,
Pages 868-875
Relative Abuse
Liability of Indiplon and Triazolam
in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects
Lawrence P. Carter, Roland R. Griffiths, Patricia E. Suess,
John H. Casada, Christopher L. Wallace, and John D. Roache
Noradrenergic Mechanisms in
Cocaine-Induced Reinstatement of Drug Seeking in Squirrel Monkeys
Donna M. Platt, James K. Rowlett, and Roger D. Spealman
A
Double-Blind, Placebo-Controlled Pilot Trial of Quetiapine
for the Treatment of Type A and Type B Alcoholism
Kampman, Kyle M; Pettinati,
Helen M; Lynch, Kevin G; Whittingham, Tom; Macfadden, Wayne; Dackis,
Charles; Tirado, Carlos; Oslin,
David W; Sparkman, Thorne; O'Brien, Charles P
Journal of Clinical
Psychopharmacology. 27(4):344-351,
August 2007
A
12-Week Double-Blind, Placebo-Controlled Study of Bupropion
SR Added to High-Dose Dual Nicotine Replacement Therapy for Smoking Cessation
or Reduction in Schizophrenia
Evins, A. Eden; Cather, Corinne; Culhane, Melissa A; Birnbaum,
Alan; Horowitz, Jonathan; Hsieh, Elaine; Freudenreich,
Oliver; Henderson, David C.; Schoenfeld, David A; Rigotti, Nancy A; Goff, Donald C
Journal of Clinical Psychopharmacology.
27(4):380-386, August 2007
A Randomized,
Placebo-Controlled Clinical Trial of Bupropion for
the Prevention of Smoking in Children and Adolescents With
Attention-Deficit/Hyperactivity Disorder
Michael C. Monuteaux,
Thomas J. Spencer, Stephen V. Faraone, Angela M.
Wilson, and Joseph Biederman
J Clin Psychiatry 2007;68:1094-1101
A pharmacological
analysis of stimulant-induced increases in smoking
Andrea R. Vansickel,
William W. Stoops, Paul E. A. Glaser and
Craig R. Rush
Psychopharmacology. Volume 193, Number 3 /
August, 2007: 305-313
Varenicline, an alpha4-beta2 nicotinic acetylcholine receptor partial
agonist, selectively decreases ethanol consumption and seeking
Pia Steensland, Jeffrey A. Simms, Joan Holgate,
Jemma K. Richards, and Selena E. Bartlett
PNAS | July 24, 2007
| vol. 104 | no. 30 | 12518-12523
Dihydrocodeine as effective as methadone for maintenance
of treatment for opiate dependence?
Robertson JR, Raab
GM, Bruce M, et al.
Evidence-Based Mental Health
2007;10:88
A key role for corticotropin-releasing factor in alcohol dependence
Markus Heilig and George F. Koob
Trends in Neurosciences. Volume 30, Issue 8,
August 2007, Pages 399-406
Monitored Naltrexone without Counseling for Alcohol Abuse/Dependence
in Schizophrenia-Spectrum Disorders
Steven L. Batki;
Jacqueline A. Dimmock; Michael Wade; Paul
W. Gately; Martha Cornell; Stephen A. Maisto; Kate B. Carey; Robert Ploutz-Snyder
American Journal on
Addictions, Volume 16, Issue 4 July 2007, pages 253 - 259
Comparison of Olanzapine to Risperidone in
Substance-Abusing Individuals with Schizophrenia
Evaristo Akerele;
Frances R. Levin
American Journal on
Addictions, Volume 16, Issue 4 July 2007, pages 260 - 268
Methamphetamine
Dependence: A Closer Look at Treatment Response and Clinical Characteristics
Associated with Route of Administration in Outpatient Treatment
Richard A. Rawson;
Rachel Gonzales; Patricia Marinelli-Casey;
Alfonso Ang
American Journal on
Addictions, Volume 16, Issue 4 July 2007, pages 291 - 299
Experimentally-Induced
Spontaneous Opiate Withdrawal: Relationship to Cigarette Craving and Expired
Air Carbon Monoxide
Michelle R. Lofwall; Sharon L. Walsh; George E. Bigelow; Eric C.
Strain
American Journal on
Addictions, Volume 16, Issue 4 July 2007, pages 310 - 315
Cannabis use and
risk of psychotic or affective mental health outcomes: a systematic review
Theresa HM Moore,
The Lancet.
Volume 370, Issue 9584, 28 July 2007-3 August 2007, Pages 319-328
Recognition and
Management of Depression in a Substance Use Disorder Treatment Population
G. M. Curran; B.
M. Booth; J. E. Kirchner; D. E. Deneke
The American
Journal of Drug and Alcohol Abuse, Volume 33, Issue 4 July 2007
, pages 563 - 569